跳至主要内容
临床试验/RBR-7m3rvth
RBR-7m3rvth进行中(未招募)1 期

Modulation of the inflammatory profile in Cancer patients supplemented with Leucine

Márcia Fábia Andrade Santos0 个研究点开始时间: 2022年5月16日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
50Y 至 80Y(—)

入选标准

  • Patients with head and neck cancer (CCP) histologically confirmed by biopsy and pathological anatomy, with weight loss above 5% in the last 12 months or body mass index (BMI) less than 20 kg/m²

排除标准

  • Obesity (BMI equal or greater than 30kg/m²); preexisting inflammatory diseases; autoimmune diseases; chronic use of anti-inflammatory drugs and/or steroids; unbalanced diabetes mellitus; use of protein supplements; regular physical activity; use of probe for feeding.

研究者

发起方
Márcia Fábia Andrade Santos

相似试验